Hematology
Volume 24, 2019 - Issue 1
Articles
A systematic review and meta-analysis of the efficacy and adverse events of azacitidine-plus-lenalidomide treatment for patients with acute myeloid leukemia, myelodysplastic syndromes and chronic myelomonocytic leukemiaFootnote11 Supplemental data for this article can be accessed https://doi.org/10.1080/16078454.2019.1631425.
, , 
, &
Patompong UngprasertClinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailandhttps://orcid.org/0000-0002-4817-9404
https://orcid.org/0000-0002-4817-9404, & Weerapat OwattanapanichDivision of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandCorrespondence[email protected]
https://orcid.org/0000-0002-1262-2005
https://orcid.org/0000-0002-1262-2005